Profound Medical Inc

Profound Medical team is committed to creating the powerful combination of real-time MR guidance as the imaging platform and ultrasound as the energy source for delivering non-invasive ablative tools to clinicians. These key technology pillars, linked with intelligent software and robotics, have the potential to fulfill unmet needs of patients and clinicians in many anatomies and disease states, including prostate cancer, uterine fibroids, and bone metastases. Our mission is to profoundly change the standard of care by creating a tomorrow where clinicians can confidently ablate tissue with precision; a tomorrow where patients have access to safe and effective treatment options, so they can quickly return to their daily lives.

Profound Medical Inc headquartered in North America, operates in the Health Care, Medical Device, Health Diagnostics sector. The company focuses on Health Care and has secured $39.0B in funding across 156 round(s). With a team of 101-250 employees, Profound Medical Inc is actively contributing to advancements in Health Care. Their latest funding round, Series A - Profound Medical Inc, raised $9.6M. Discover more about their projects, partnerships, and impact on our platform.